Showing results (1-10 of 255) with videos related to
Sort By:
Pageof 26
Psychopharmacology Bulletin|October 26, 2002
Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)C L DeVane, J S Markowitz, H L Liston, et al.Journal of Clinical Psychopharmacology|October 11, 2001
Drug glucuronidation in clinical psychopharmacologyH L Liston, J S Markowitz, C L DeVaneInternational Clinical Psychopharmacology|December 8, 2000
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopramJ S Markowitz, C L DeVane, H L Liston, et al.Psychopharmacology Bulletin|October 26, 2002
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacologyC L DeVane, H L ListonLife Sciences|March 4, 2000
Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteersJ S Markowitz, C L DeVane, D W Boulton, et al.Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVaneBulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S MarkowitzThe Journal of ECT|December 4, 2001
Intranasal sumatriptan in post-ECT headache: results of an open-label trialJ S Markowitz, C H Kellner, C L DeVane, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2000
Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanolJ S Markowitz, C L DeVane, D W Boulton, et al.Journal of Clinical Psychopharmacology|June 1, 2000
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizersC L DeVane, J S Markowitz, S W Carson, et al.Pageof 26